Overview
- Broadens reader understanding of the role of nanomedicine as an alternative treatment strategy for cancer theranostics
- Illustrates the cross-disciplinary nature of cancer nanotheranostics
- Enriches understanding of how nanomaterials can be used as effective carriers to target cancer cells
Part of the book series: Nanotechnology in the Life Sciences (NALIS)
Buy print copy
About this book
In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies.
This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics.
Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.
Similar content being viewed by others
Keywords
Table of contents (13 chapters)
Editors and Affiliations
About the editors
Hamed Barabadi (PharmD, PhD) works as an Assistant Professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He obtained his PhD at Shahid Beheshti University of Medical Sciences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. Prior to starting his PhD, he served as a pharmaceutical expert at the Food and Drug Administration at the Department of Inspection and Supervision in Golestan Province, Iran, for two years. He owns to his credit a number of research papers and book chapters. He has received many awards such as IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020. Dr. Barabadi has beenfeatured among the World's Top 2% Scientists List, according to a Stanford University study 2020. He is Guest editor/Editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, Biocell, etc. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization and optimization of nanobiomaterials to their pharmaceutical potential evaluations such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine.
Bibliographic Information
Book Title: Cancer Nanotheranostics
Book Subtitle: Volume 2
Editors: Muthupandian Saravanan, Hamed Barabadi
Series Title: Nanotechnology in the Life Sciences
DOI: https://doi.org/10.1007/978-3-030-76263-6
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-76262-9Published: 06 October 2021
Softcover ISBN: 978-3-030-76265-0Published: 06 October 2022
eBook ISBN: 978-3-030-76263-6Published: 05 October 2021
Series ISSN: 2523-8027
Series E-ISSN: 2523-8035
Edition Number: 1
Number of Pages: XIV, 368
Number of Illustrations: 2 b/w illustrations, 47 illustrations in colour
Topics: Cancer Research, Biotechnology, Materials Science, general